Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLondon Capital Group Holdings Regulatory News (LCG)

  • There is currently no data for LCG

Directorate Change

18 Jul 2013 07:00

RNS Number : 5798J
London Capital Group Holdings PLC
18 July 2013
 



London Capital Group Holdings plc

("LCG" or the "Company")

Directorate changes

The Company announces that Mark Slade has today resigned his position as CEO of the Company for personal reasons. His resignation will take effect immediately although he will remain as a strategic adviser to the Company for the remainder of the year to ensure a smooth transition period. He also continues to be a shareholder in the Company.

The Board is pleased to announce that Kevin Ashby, 55, has been appointed to replace Mark Slade as CEO with immediate effect.

Kevin recently joined LCG as Chief Commercial Officer and was previously Chairman & Chief Executive of Saxo Capital Markets and responsible for Saxo Bank's operations in Asia Pacific. He was formerly CEO of Patsystems, a UK listed financial software company; Chairman of Velsys, a trading systems supplier; and CEO of WISe, the insurance e-commerce network. He was formerly an IT Partner and CIO at KPMG. Kevin's appointment is subject to regulatory approval.

Kevin has extensive knowledge of the retail derivatives industry having held a number of senior roles both in the UK and internationally. 

The Board is also pleased to announce that it has further strengthened the Company's management team with the appointment of John Jones as Chief Operating Officer and Head of Risk Management. John was previously European COO and Head of Risk at Liquid Capital, a specialist derivative trading firm and prior to that he held senior trading roles at both Bear Stearns and Citigroup. John's expertise of trading, operations and risk management will be of great benefit to those areas of the firm.

Giles Vardey, Chairman of LCG, said: 'The Board is sorry that Mark has made this personal choice but we all respect the reason for his decision. All members of the board wish him well and we are pleased that we have been able to promote Kevin Ashby to CEO. Kevin has a great deal of experience in our sector and has been a CEO in the past. His strategic vision and skills will continue to drive the improvements we are already making in the business. Kevin will also lead a strengthened management team with a new COO in John Jones.

Save as disclosed below there are no additional disclosures to be made in accordance with paragraph (g) of Schedule 2 of the AIM Rules in relation to Kevin Ashby.

Kevin Ashby has held the following directorships in the past five years:

KD Advisory Limited*

London Capital Group Limited*

Velsys Limited

Syncova Solutions Limited

 

*current directorships

Kevin Ashby was a director of PatSystems plc between 11 December 2002 and 3 January 2006 which entered in to a scheme of arrangement in 2003 in order to effect a distribution of excess capital to shareholders and move the company's listing from the main market to AIM.

Kevin Ashby was a director of Velsys Pte (Australia) a subsidiary of Velsys Limited between 14 September 2010 and 4 July 2011 which was placed into administration in 2011. Velsys settled with administrators in late 2012.

 For further information, please contact: 

 www.londoncapitalgroup.com

 

London Capital Group Holdings plc

Giles Vardey

Chairman

020 7456 7000

 

Cenkos Securities plc

Nicholas Wells/Camilla Hume

020 7397 8900

Smithfield Consultants

John Kiely

020 7360 4900

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGURUMUPWPPM
Date   Source Headline
24th Sep 20157:00 amRNSHalf Yearly Report
28th Jul 201512:13 pmRNSIssue of Equity
21st May 201510:34 amRNSResult of AGM
13th May 20159:44 amRNSAnnual Financial Report and AGM
29th Apr 20159:58 amRNSHolding(s) in Company
21st Apr 201511:14 amRNSHolding(s) in Company
8th Apr 201510:25 amRNSHolding(s) in Company
31st Mar 20153:56 pmRNSDirector/PDMR Shareholding
30th Mar 20156:13 pmRNSDirector/PDMR Shareholding
25th Mar 20156:20 pmRNSDirector/PDMR Shareholding
25th Mar 20157:15 amRNSDirectorate Change
25th Mar 20157:00 amRNSFinal Results
20th Mar 20154:40 pmRNSSecond Price Monitoring Extn
20th Mar 20154:35 pmRNSPrice Monitoring Extension
27th Feb 201511:11 amRNSHolding(s) in Company
6th Feb 201511:41 amRNSHolding(s) in Company
6th Feb 201511:38 amRNSHolding(s) in Company
30th Jan 20154:23 pmRNSHolding(s) in Company
28th Jan 20154:44 pmRNSConversion of Loan Notes and Issue of Equity
27th Jan 201510:34 amRNSHolding(s) in Company
26th Jan 20152:20 pmRNSDirector's Shareholding and JSOP Allocations
23rd Jan 20157:00 amRNSReplacement - Conversion of Loan Notes
22nd Jan 201510:45 amRNSDirector/PDMR Shareholding
21st Jan 20154:02 pmRNSConversion of Loan Notes
16th Jan 201510:25 amRNSStatement on Swiss Franc movement
16th Jan 20158:45 amRNSConversion of Loan Notes and Issue of Equity
15th Jan 20157:00 amRNSPre-Close Trading Update
23rd Dec 20147:00 amRNSDirectorate Change
22nd Dec 20146:26 pmRNSDirector/PDMR Shareholding
10th Dec 20145:48 pmRNSTransaction in Own Shares & Director Dealing
3rd Dec 20143:36 pmRNSHolding(s) in Company
1st Dec 201411:40 amRNSFunding of Employee Benefit Trust
27th Nov 20147:00 amRNSDirector/PDMR Shareholding
14th Nov 20145:15 pmRNSTransaction in Own Shares & Amendment
14th Nov 20147:00 amRNSTransaction in Own Shares
7th Nov 20147:00 amRNSDirectorate Change
22nd Oct 20147:00 amRNSInterim Management Statement
21st Oct 20146:29 pmRNSDirectorate Change
20th Oct 20145:49 pmRNSCompletion of Licencing Agreement
17th Oct 20147:00 amRNSCompletion of Financing
1st Oct 20144:11 pmRNSFinancing Update
30th Sep 201411:57 amRNSResult of EGM
15th Sep 20147:00 amRNSEntry into Software as a Service Agreement
11th Sep 201412:24 pmRNSDirectorate Change
4th Sep 20148:30 amRNSAmend. re. Directorate Change
3rd Sep 20144:17 pmRNSDirectorate Change
27th Aug 20147:00 amRNSINTERIM RESULTS
14th Aug 20144:37 pmRNSFinancing update - FCA Approvals
31st Jul 20144:26 pmRNSDirectorate Change
17th Jul 20147:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.